HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenjiro Sawada Selected Research

Anemia

1/2022Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenjiro Sawada Research Topics

Disease

61Neoplasms (Cancer)
03/2022 - 11/2002
32Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 11/2002
12Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2021 - 07/2014
11Neoplasm Metastasis (Metastasis)
11/2021 - 12/2002
10Carcinoma (Carcinomatosis)
09/2018 - 04/2005
5Endometrial Neoplasms (Endometrial Cancer)
03/2022 - 02/2015
5Carcinogenesis
11/2021 - 02/2008
5Adenocarcinoma
10/2017 - 06/2011
5Ascites
01/2015 - 01/2005
4Ovarian Epithelial Carcinoma
01/2021 - 11/2018
4Osteoporosis
01/2017 - 11/2002
4Hypoxia (Hypoxemia)
05/2015 - 10/2004
3Postmenopausal Osteoporosis
01/2020 - 06/2003
3Infections
03/2016 - 02/2007
2Uterine Neoplasms (Uterine Cancer)
03/2022 - 01/2018
2Endometriosis
01/2022 - 08/2016
2Chorioamnionitis
03/2016 - 11/2013
2Inflammation (Inflammations)
03/2016 - 11/2013
1Anemia
01/2022
1Fatigue
01/2022
1Diarrhea
09/2021
1Venous Thromboembolism
11/2019
1Breast Neoplasms (Breast Cancer)
03/2019
1Thrombocytosis (Thrombocythemia)
01/2019
1Leukocytosis (Pleocytosis)
01/2019

Drug/Important Bio-Agent (IBA)

8MicroRNAs (MicroRNA)IBA
01/2020 - 05/2013
8Proteins (Proteins, Gene)FDA Link
08/2019 - 11/2002
8IntegrinsIBA
01/2019 - 02/2007
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021 - 07/2014
5PlatinumIBA
10/2019 - 12/2015
5Pharmaceutical PreparationsIBA
01/2019 - 04/2007
5Cisplatin (Platino)FDA LinkGeneric
11/2018 - 09/2009
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2016 - 03/2007
5lysophosphatidic acidIBA
12/2009 - 11/2002
5rho-Associated KinasesIBA
12/2009 - 11/2002
5Tyrosine (L-Tyrosine)FDA Link
04/2007 - 11/2002
4Indicators and Reagents (Reagents)IBA
01/2021 - 06/2011
4Neutralizing AntibodiesIBA
03/2019 - 07/2014
4Interleukin-6 (Interleukin 6)IBA
01/2019 - 11/2013
4Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2009 - 11/2002
3Mevalonic Acid (Mevalonate)IBA
01/2021 - 11/2002
3Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 01/2015
3Biological ProductsIBA
03/2019 - 07/2014
3Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 06/2014
3Biomarkers (Surrogate Marker)IBA
09/2018 - 01/2014
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2017 - 02/2007
3Phosphotransferases (Kinase)IBA
05/2016 - 02/2007
3Messenger RNA (mRNA)IBA
04/2009 - 10/2004
3Diphosphonates (Bisphosphonates)IBA
01/2005 - 11/2002
2TOR Serine-Threonine KinasesIBA
12/2020 - 09/2009
2Dinoprostone (PGE2)FDA Link
12/2020 - 11/2018
2YM 529IBA
01/2020 - 01/2017
2PM 01183IBA
10/2019 - 01/2016
2LipidsIBA
08/2019 - 02/2015
2Estrogens (Estrogen)FDA Link
03/2019 - 01/2018
2Celecoxib (Celebrex)FDA Link
01/2019 - 11/2018
2VitronectinIBA
11/2018 - 10/2017
2taxaneIBA
10/2018 - 12/2017
2Raloxifene Hydrochloride (Evista)FDA Link
01/2017 - 02/2015
2Small Interfering RNA (siRNA)IBA
01/2017 - 02/2007
2CytokinesIBA
03/2016 - 11/2013
2Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 12/2009
2Bevacizumab (Avastin)FDA Link
04/2015 - 08/2010
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2015 - 11/2013
2TrabectedinIBA
06/2014 - 07/2011
2EverolimusFDA Link
07/2011 - 09/2009
2Oxygen (Dioxygen)IBA
09/2009 - 10/2004
2Cadherins (E-Cadherin)IBA
09/2009 - 04/2008
2Peptide Hydrolases (Proteases)FDA Link
02/2008 - 02/2007
2geranylgeranylacetone (teprenone)IBA
04/2007 - 04/2005
2NitrogenIBA
01/2005 - 11/2002
1ninjin'yoeitoIBA
01/2022
1Asu(1,6)- argipressin (VAS-A)IBA
01/2022
1Hemoglobins (Hemoglobin)IBA
01/2022
1IronIBA
01/2022
1Galectin 3 (LGALS3)IBA
01/2022
1GW 4869IBA
01/2021
1Farnesyl-Diphosphate Farnesyltransferase (Squalene Synthase)IBA
01/2021
1SqualeneIBA
01/2021
1Ubiquitin-Specific ProteasesIBA
01/2021
1B7-H1 AntigenIBA
12/2020
1Aldehyde Dehydrogenase 1 FamilyIBA
12/2020
1DenosumabFDA Link
01/2020
1AnticoagulantsIBA
11/2019
1Vitamin KFDA Link
11/2019
1Nucleic AcidsIBA
08/2019
1Estrogen ReceptorsIBA
03/2019
1Fibronectins (Fibronectin)IBA
11/2018

Therapy/Procedure

23Therapeutics
01/2022 - 12/2002
6Drug Therapy (Chemotherapy)
01/2019 - 01/2015
6Hysterectomy
10/2017 - 01/2012
5Radiotherapy
09/2021 - 07/2014
3Aftercare (After-Treatment)
01/2022 - 02/2015
2Laparotomy
03/2022 - 03/2011
2Lymph Node Excision (Lymph Node Dissection)
03/2022 - 02/2015
2Kampo Medicine (Kampo)
01/2022 - 01/2018
2Brachytherapy
05/2021 - 03/2019
2Combination Drug Therapy (Combination Chemotherapy)
10/2018 - 12/2017
2Splenectomy
12/2015 - 07/2014
1Chemoradiotherapy
09/2021